Cartesian Therapeutics
RNAC
#7439
Rank
A$0.50 B
Marketcap
$18.98
Share price
3.21%
Change (1 day)
-43.67%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.48

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.50. In 2021 the company made an earnings per share (EPS) of -$0.37 an increase over its 2020 EPS that were of -$1.07.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.48
2021-$0.37-65.22%
2020-$1.07-43.44%
2019-$1.90-58.08%
2018-$4.52-9.35%
2017-$4.99-29.16%
2016-$7.04